A Golden Age for 3D Printing Healthcare Industry

The world's 3D printing healthcare industry is driven by several innovations, such as multi-color full-color 3D printers that are primarily solar portable. Public and private organizations are also driving market growth by investing in R & D activities. Also, the ability of 3D printing technology to provide tailor-made medical devices and increase the set of usable biomaterials is expected to drive market growth. In addition, market growth accelerated as the number of elderly people increased, the incidence of osteoporosis increased, the number of amputees increased, the number of patients with hearing loss and tooth problems increased. Moreover, as the use of this technology in hospitals increases, the duration of surgery, exposure to anesthesia and the risk of surgery will be reduced, effective preoperative planning will be provided, and physician work will be improved to promote faster healing. In addition to the aforementioned factors, the 3D printing organization also supports market growth by shortening the duration of clinical trials and reducing the costs and inherent risks associated with testing new drugs by providing a highly desirable alternative for animal testing. However, the high costs associated with high-end 3D printers, the absence of structured regulatory frameworks and compensation policies, and copyright and patent issues related to 3D printing of patented products are expected to hamper market growth.

External wearable device applications are expected to continue to lead the 3D printing healthcare market during the forecast period due to increased availability of cutters, hearing loss patients, tooth problems and biocompatible materials. In addition, the production of custom tailored 3D wearable externally wearable devices is expected to foster market growth by meeting the patient's customized needs and providing better fitting and comfort. 3D printing technology is used in more accurate and less invasive medical procedures in dental practice.

For More Information, Download Sample: https://www.alliedmarketresearch.com/request-sample/834

The 3D printing systems market will see significant growth in Asia Pacific and LAMEA as the number of startups grows and their awareness increases. The material segments are expected to grow at significant growth rates due to increased availability of biocompatible materials, efficient material use, and simultaneous use of multiple materials. In North America and Europe, the materials market is expected to grow rapidly due to the existing system market.

Key findings of 3D Printing Healthcare Market:

• The 3D healthcare services segment is projected to exhibit the highest CAGR of 26.6% during the forecast period.
• Polymers are the most preferred materials for 3D printing, as they account for about half of the market revenue in the materials market; whereas, the ceramics    segment is projected as the fastest growing segment with a CAGR of 32.1% during the forecast period.
• The electron beam melting technology segment is projected to grow at the highest CAGR of 29.6% from 2015 to 2020.
• The medical and surgical centers end user segment accounts for two-thirds of the market and are expected to dominate the market until 2020.
• The tissue engineering application segment would emerge as the fastest growing segment, registering a CAGR of 31.7% during the forecast period.

North America accounted for two-fifths share of the healthcare 3D printing market, whereas the Asia-Pacific is anticipated to be the fastest growing market, registering a CAGR of 29.7% from 2015 to 2020.

The 3D printing healthcare market is largely consolidated, as majority of the market share is governed by the two leading players, 3D Systems Corporations and Stratasys Ltd. In addition, the key market players have adopted strategic partnership to accelerate the product development process. The major companies profiled in this report include 3D Systems Corporation, Stratasys Ltd., SLM Solutions Group AG, EnvisionTEC, Arcam AB, Organovo Holdings, Inc., Oxford Performance Materials, Inc., Materialise NV, Bio3D Technologies, and Cyfuse Medical K.K.